Combination therapy with ARA-AMP and interferon of chronic active hepatitis B. Interim analysis of an ongoing study.
Trépo
C
C
Hepatogastroenterology Unit, Hôtel-Dieu Hospital, Lyon, France.
Rougier
P
P
Bizollon
T
T
Poupon
R
R
Zarski
J P
JP
Quinton
A
A
Miguet
J P
JP
Causse
X
X
Chossegros
P
P
Chevallier
M
M
D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006509:Hepatitis B / Q000188:drug therapy* / Q000628:therapy; D006511:Hepatitis B Antigens / Q000032:analysis; D006515:Hepatitis B virus / Q000276:immunology; D006521:Hepatitis, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D011994:Recombinant Proteins; D001084:Vidarabine Phosphate / Q000627:therapeutic use*; D014779:Virus Replication
D006511:Hepatitis B Antigens; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D001084:Vidarabine Phosphate